CTXR Earnings Citius Pharmaceuticals, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q2 2026 | 2026-03-31 | -1.34 | 2026-05-15 | 10-Q |
| Q1 2026 | 2025-12-31 | -0.38 | 2026-02-13 | 10-Q |
| FY 2025 | 2025-09-30 | -3.38 | 2025-12-23 | 10-K |
| Q3 2025 | 2025-06-30 | -3.27 | 2025-08-12 | 10-Q |
| Q2 2026 | 2025-03-31 | -2.58 | 2026-05-15 | 10-Q |
| Q1 2026 | 2024-12-31 | -1.30 | 2026-02-13 | 10-Q |
| FY 2025 | 2024-09-30 | -5.97 | 2025-12-23 | 10-K |
| Q3 2025 | 2024-06-30 | -4.37 | 2025-08-12 | 10-Q |
| Q2 2025 | 2024-03-31 | -2.79 | 2025-05-14 | 10-Q |
| Q1 2025 | 2023-12-31 | -1.45 | 2025-02-14 | 10-Q |
| FY 2024 | 2023-09-30 | -5.57 | 2024-12-27 | 10-K |
| Q3 2023 | 2023-06-30 | -0.15 | 2023-08-14 | 10-Q |
| Q2 2023 | 2023-03-31 | -0.10 | 2023-05-12 | 10-Q |
| Q1 2023 | 2022-12-31 | -0.02 | 2023-02-10 | 10-Q |
| FY 2022 | 2022-09-30 | -0.23 | 2022-12-22 | 10-K |
| Q3 2023 | 2022-06-30 | -0.18 | 2023-08-14 | 10-Q |
| Q2 2023 | 2022-03-31 | -0.11 | 2023-05-12 | 10-Q |
| Q1 2023 | 2021-12-31 | -0.06 | 2023-02-10 | 10-Q |
| FY 2022 | 2021-09-30 | -0.23 | 2022-12-22 | 10-K |
| Q3 2022 | 2021-06-30 | -0.20 | 2022-08-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.